Publications by authors named "Basel Almalki"
Abemaciclib is a cyclin-dependent kinase 4/6 inhibitor that is utilized to manage hormone-sensitive human epidermal growth factor receptor-2 positive metastatic breast cancer. Palbociclib and ribociclib are types of other orally administered CDK4/6i that share similar safety and tolerability compared with Abemaciclib. Reported side effects include reversible neutropenia of a lower grade, gastrointestinal toxicity, and anemia.
View Article and Find Full Text PDFRecalcitrant Dissecting Cellulitis of the Scalp Treated Successfully with Adalimumab with Hair Regrowth: A Case Report.
Clin Cosmet Investig Dermatol
May 2021
Article Synopsis
- Dissecting cellulitis (DC) is a rare chronic scalp condition characterized by pustules, nodules, abscesses, and scarring that leads to hair loss.
- Treatment options for DC are often difficult and not very effective.
- A 38-year-old male with a 5-year history of DC experienced significant regrowth of hair after being treated with adalimumab.